Inverness Medical Innovations clinical trials
Acquired by Abbott, Oct 3, 2017 · source ↗
The registry lists 2 studies whose lead sponsor is Inverness Medical Innovations. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 12, 2009.
Before and after it joined Abbott
- First submitted before Inverness Medical Innovations became part of Abbott
- 2
- First submitted after Inverness Medical Innovations became part of Abbott
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Inverness Medical Innovations2 studies
Something wrong with this grouping? Tell us on the Abbott page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Abbott studies →
- The Ischemia Modified Albumin In Diagnosing Ischemic New EventsTerminatedNCT00355992
Sponsor listed in the registry: Inverness Medical Innovations · First submitted before Inverness Medical Innovations became part of Abbott
- The Utility of Ischemia Modified Albumin (IMA) in SepsisCompletedNCT00448968
Sponsor listed in the registry: Inverness Medical Innovations · First submitted before Inverness Medical Innovations became part of Abbott